Lisa M. Kaminskas

Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy

Lisa M. Kaminskas, Victoria M. McLeod, Gemma M. Ryan et al. · Journal of Controlled Release · 2014 · 188 citations

Pharmacy, Oncology, Pharmacology +17

The Impact of Molecular Weight and PEG Chain Length on the Systemic Pharmacokinetics of PEGylated Poly <scp>l</scp>-Lysine Dendrimers

Lisa M. Kaminskas, Ben J. Boyd, Peter Karellas et al. · Molecular Pharmaceutics · 2008 · 177 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems

Lisa M. Kaminskas, Victoria M. McLeod, Brian D. Kelly et al. · Nanomedicine Nanotechnology Biology and Medicine · 2011 · 171 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Cationic Poly- <scp>l</scp> -lysine Dendrimers:  Pharmacokinetics, Biodistribution, and Evidence for Metabolism and Bioresorption after Intravenous Administration to Rats

Ben J. Boyd, Lisa M. Kaminskas, Peter Karellas et al. · Molecular Pharmaceutics · 2006 · 163 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats

Lisa M. Kaminskas, Jagannath Kota, Victoria M. McLeod et al. · Journal of Controlled Release · 2009 · 144 citations

Pharmacy, Pharmaceutics, Pharmacology +12